## Correct Answer: C. Propranolol Propranolol is the gold-standard **first-line prophylactic agent** for migraine in patients with comorbid cardiovascular risk factors. This patient has a family history of coronary artery disease (CAD), making her a high-risk candidate for future cardiac events. Propranolol, a non-selective beta-blocker, not only prevents migraine attacks through mechanisms including reduced cerebral blood flow, stabilization of serotonergic neurotransmission, and decreased platelet aggregation, but also provides **cardioprotective benefits** by reducing blood pressure, heart rate, and myocardial oxygen demand. This dual benefit—migraine prophylaxis + cardiovascular protection—makes it the ideal choice in this clinical scenario. Triptans like sumatriptan are acute abortive agents, not prophylactic drugs, and their vasoconstrictive properties are contraindicated in patients with CAD risk. Beta-blockers (propranolol, metoprolol, timolol) are Class A evidence for migraine prophylaxis per Indian neurology guidelines and international consensus. The patient's prior response to sumatriptan confirms migraine diagnosis but does not alter the prophylaxis strategy—prophylaxis is indicated when attacks occur ≥4 days/month or cause significant disability, and cardiovascular comorbidity shifts the choice toward beta-blockers. ## Why the other options are wrong **A. Topiramate** — While topiramate is an effective migraine prophylactic (anticonvulsant mechanism via GABA enhancement and carbonic anhydrase inhibition), it offers **no cardiovascular protection** and carries metabolic side effects (weight loss, cognitive dulling, nephrolithiasis risk). In a patient with CAD family history, topiramate is a second-line choice when beta-blockers are contraindicated or ineffective. NBE may trap students who know topiramate is prophylactic but forget the cardioprotective advantage of beta-blockers in high-risk patients. **B. Naratriptan** — Naratriptan is a **selective 5-HT1B/1D agonist triptan**—an acute abortive agent, not a prophylactic drug. Like sumatriptan, it causes cerebral and coronary vasoconstriction, making it **contraindicated in patients with CAD risk**. Triptans are used to abort individual migraine attacks, not to prevent them. This is a classic NBE trap: confusing acute therapy (triptans) with preventive therapy (beta-blockers, anticonvulsants, calcium-channel blockers). **D. Ergotamine** — Ergotamine is an **ergot alkaloid with potent vasoconstrictive properties**—it is an acute abortive agent, not prophylactic. More critically, ergotamine causes **sustained vasoconstriction and increases coronary vasomotor tone**, making it absolutely contraindicated in patients with CAD or CAD risk factors. Ergotamine is rarely used in modern Indian practice due to poor tolerability and cardiac risk; it is obsolete for this patient. NBE may include it to test whether students recognize that vasoconstrictors are dangerous in cardiac-risk patients. ## High-Yield Facts - **Propranolol** is Class A evidence (first-line) for migraine prophylaxis and provides dual benefit: migraine prevention + cardiovascular protection in high-risk patients. - **Triptans** (sumatriptan, naratriptan) are acute abortive agents, NOT prophylactic drugs; they cause vasoconstriction and are contraindicated in CAD/CAD-risk patients. - **Migraine prophylaxis indications**: ≥4 attacks/month, severe/disabling attacks, or contraindication to acute therapy; choice depends on comorbidities (beta-blockers for HTN/CAD risk, anticonvulsants for epilepsy, TCAs for depression). - **Ergotamine** is contraindicated in CAD/CAD-risk due to sustained coronary vasoconstriction; rarely used in modern Indian practice. - **Other beta-blockers** effective for migraine prophylaxis: metoprolol, timolol, atenolol; propranolol preferred due to additional serotonergic effects. ## Mnemonics **ABCDE of Migraine Prophylaxis** **A**mitriptyline (TCA), **B**eta-blockers (propranolol), **C**alcium-channel blockers (verapamil), **D**ivalproex/topiramate (anticonvulsants), **E**rgot alkaloids (avoid). Choose based on comorbidities: beta-blockers for CAD risk. **Triptan ≠ Prophylaxis** **Triptans = Acute abortive** (sumatriptan, naratriptan, zolmitriptan). **Prophylaxis = Beta-blockers, anticonvulsants, TCAs, CCBs**. Triptans cause vasoconstriction → contraindicated in CAD-risk patients. ## NBE Trap NBE pairs a patient on acute triptan therapy with a prophylaxis question to trap students who confuse abortive agents (triptans) with preventive agents (beta-blockers). The CAD family history is the discriminating clue: only propranolol offers both migraine prevention AND cardioprotection, while triptans and ergotamine are contraindicated due to vasoconstriction. ## Clinical Pearl In Indian clinical practice, propranolol remains the most prescribed migraine prophylactic, especially in patients with concurrent hypertension or CAD family history—a common scenario in urban Indian populations. A patient on sumatriptan for acute attacks should be counseled to start prophylaxis if attacks exceed 4/month; propranolol's dual benefit makes it the natural choice when cardiovascular risk is present. _Reference: KD Tripathi Pharmacology Ch. 11 (Migraine Management); Harrison Ch. 434 (Headache); Robbins Ch. 28 (Nervous System Pathology)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.